News

An Affiliate of Sun European Partners, LLP, completes the sale of NextPharma

Sun European Partners, LLP (“Sun European Partners” or “Sun”) today announces that one of its affiliates has completed the sale of its investment in NextPharma (or “the company”), a leading pharmaceutical contract development and manufacturing organisation, to Funds advised by CapVest Partners LLP.

NextPharma was acquired by an affiliate of Sun European Partners in 2011. Over the last six years, Sun has more than doubled NextPharma’s profitability by optimising the manufacturing footprint, improving the company’s efficiencies and increasing top line growth above market levels.

Lionel de Posson, Principal at Sun European Partners, said: “Once again, the strategy employed by Sun European Partners has allowed for a successful exit and we are delighted with the progress made by the company during our ownership.”

Privacy Overview

This website uses cookies to improve your experience. This includes cookies that are necessary to enable the website’s core functionality. We'd also like to set optional analytics cookies to help improve it further, however we won't set these unless you opt in. These analytics cookies provide us with statistics and information on how you use the website. For more detailed information about the cookies used on this website, see our Cookies Policy.

Necessary Cookies
Always Enabled
Analytics Cookies